Samuel Eugene Lynch serves as Executive at BIOMIMETIC THERAPEUTICS, INC., where they oversee executive responsibilities. Since joining the company, Samuel Eugene Lynch has executed 204 insider transactions totaling $6.2M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 14, 2008 involved receiving (via award) 604 shares valued at $10.0K.
Samuel Eugene Lynch currently holds 1,300,546 shares of BIOMIMETIC THERAPEUTICS, INC. (BMTI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Samuel Eugene Lynch has been a net seller of BMTI stock. They have purchased $455.1K and sold $5.7M worth of shares.
Samuel Eugene Lynch's most recent insider trade was on Jan 14, 2008, when they sold 604 shares at $16.56 per share.
Get notified when new Form 4 filings are submitted
| $17.15 |
| Discretionary |
| May 12, 2006 | BMTI | $59.2K | Purchase | 7,400 | $8.00 | Discretionary |
| May 12, 2006 | BMTI | $40.8K | Purchase | 5,100 | $8.00 | Discretionary |